Department of Neurosurgery and Interventional Neuroradiology, Xuanwu Hospital, China International Neuroscience Institute, Capital Medical University, National Center for Neurological Disorders.
Department of Interventional Radiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu.
Int J Surg. 2024 Sep 1;110(9):5696-5703. doi: 10.1097/JS9.0000000000001766.
To investigate the association between BMI and the incidence of ischemic stroke in patients with symptomatic artery occlusion, and further to evaluate the utility of BMI as a screening tool for identifying candidates for extracranial-intracranial bypass surgery.
The authors analyzed the relationship between BMI and the occurrence of ipsilateral ischemic stroke (IIS) among patients receiving only medical management in the Carotid or Middle cerebral artery Occlusion Surgery Study (CMOSS). Additionally, the authors compared the primary endpoint of CMOSS-stroke or death within 30 days, or IIS after 30 days up to 2 years-among patients with varying BMIs who underwent either surgery or medical treatment.
Of the 165 patients who treated medically only, 16 (9.7%) suffered an IIS within 2 years. BMI was independently associated with the incidence of IIS (hazard ratio: 1.16 per kg/m 2 ; 95% CI: 1.06-1.27). The optimal BMI cutoff for predicting IIS was 24.5 kg/m 2 . Patients with BMI ≥24.5 kg/m 2 experienced a higher incidence of IIS compared to those with BMI <24.5 kg/m 2 (17.4 vs. 0.0%, P <0.01). The incidence of the CMOSS primary endpoint was significantly different between the surgical and medical groups for patients with BMI ≥24.5 kg/m 2 (5.3 vs. 19.8%, P <0.01) and those with BMI <24.5 kg/m 2 (10.6 vs. 1.4%; P =0.02). Surgical intervention was independently associated with a reduced rate of the CMOSS primary endpoint in patients with BMI ≥24.5 kg/m 2 .
Data from the CMOSS trial indicate that patients with BMI ≥24.5 kg/m 2 are at a higher risk of IIS when treated medically only and appear to derive greater benefit from bypass surgery compared to those with lower BMIs. Given the small sample size and the inherent limitations of retrospective analyses, further large-scale, prospective studies are necessary to confirm these findings.
本研究旨在探讨体质指数(BMI)与症状性动脉闭塞患者发生缺血性卒中的关系,并进一步评估 BMI 作为筛选行颅内外动脉搭桥术患者的工具的效用。
作者分析了接受颈动脉或大脑中动脉闭塞手术研究(CMOSS)仅药物治疗的患者中,BMI 与同侧缺血性卒中(IIS)发生的关系。此外,作者比较了不同 BMI 患者行手术或药物治疗后,CMOSS 的主要终点(30 天内卒中或死亡,或 30 天后至 2 年内发生 IIS)。
在仅接受药物治疗的 165 例患者中,有 16 例(9.7%)在 2 年内发生 IIS。BMI 与 IIS 的发生独立相关(风险比:每增加 1kg/m2 为 1.16;95%可信区间:1.06-1.27)。预测 IIS 的最佳 BMI 切点为 24.5kg/m2。BMI≥24.5kg/m2 的患者发生 IIS 的比例高于 BMI<24.5kg/m2 的患者(17.4%比 0.0%,P<0.01)。对于 BMI≥24.5kg/m2 的患者,手术组与药物组 CMOSS 主要终点的发生率有显著差异(5.3%比 19.8%,P<0.01),对于 BMI<24.5kg/m2 的患者,手术组与药物组 CMOSS 主要终点的发生率也有显著差异(10.6%比 1.4%,P=0.02)。在 BMI≥24.5kg/m2 的患者中,手术干预与 CMOSS 主要终点发生率降低独立相关。
CMOSS 试验的数据表明,仅接受药物治疗的 BMI≥24.5kg/m2 的患者发生 IIS 的风险更高,与 BMI 较低的患者相比,他们似乎从搭桥手术中获益更多。鉴于样本量较小且回顾性分析存在固有局限性,需要进一步开展大规模前瞻性研究来证实这些发现。